Pharmaceutical Stocks

Pharmaceutical stocks have grown tremendously as medicine advances. With diseases like Covid-19, diabetes, liver disease and other illnesses affecting more and more of the population, pharmaceutical companies are racing to find cures – further advancing medicine and driving pharma stock prices higher.

Big Pharma corporations like AstraZeneca, Merck & Co., Pfizer, and Johnson & Johnson are leading the charge against the novel coronavirus, competing with smaller biotech names — such as Moderna and Novavax. The race to find a Covid-19 vaccine has sent both pharma and biotech stocks to the moon.

Get Smooth Profits With Botox Owner

By Dan Passarelli, InvestorPlace Contributor
A covered call option on Allergan will generate returns and lower the break even on the stock.

Nike Stays Swift on Strong Earnings

By Anthony John Agnello, Consumer and Technology Writer
Midday stock trading led by Nike (NYSE: NKE), Icagen (NASDAQ: ICGN, Accenture (NYSE: ACN) and Enbridge Energy Partners (NYSE: EEP).

Continucare Skyrockets on Buyout Bid

By Anthony John Agnello, Consumer and Technology Writer
Midday trading action seen in Continucare (NYSE: CNU), Icagen (NASDAQ: ICGN), and EXCO Resources (NYSE: XCO).

Techs and European Debt Woes Weigh Down Dow

By Kyle Woodley, Senior Investing Editor, Kiplinger
Tech stocks Oracle, Micron, Microsoft, Cisco bring Dow down in early trading, and Big Pharma's Pfizer off; consumer stocks up slightly.

Southern Union Soars on Buyout Bid

By Anthony John Agnello, Consumer and Technology Writer
Midday trading led by Southern Union (NYSE: SUG), SuccessFactors (NASDAQ: SFSF), Aegerion Pharmaceuticals (NASDAQ: AEGR).

Red Hat Rises and TreeHouse Trimmed

By Anthony John Agnello, Consumer and Technology Writer
Midday trading action led by TreeHouse Foods (NYSE: THS), Bed Bath & Beyond (NASDAQL BBBY), Red Hat (NYSE: RHT).

Fidelity Select Pharmaceutical Mutual Fund Offers Diversified Drug Play

By Cynthia Wilson, Consumer Finance & Funds Writer
The Fidelity Select Pharmaceutical Portfolio offers a diversified group of big pharma stocks and biotech investments that give investors a way to play the entire sector easily.

Best Buy Rallies as Dollar Thrifty Gets a Flat

By Anthony John Agnello, Consumer and Technology Writer
Trading midday sees action in Best Buy (NYSE: BBY), Kellogg (NYSE: K), Dollar Thrifty (NYSE: DTG) and FactSet Research (NYSE: FDS).

Buy Puts on Abercrombie, Endo Pharma

By Ken Trester
Option traders should consider buying puts on Abercrombie & Fitch (NYSE: ANF) and Endo Pharmaceuticals (NASDAQ: ENDP).

Pharmaceutical Companies Hit New Highs, Solar Stocks New Lows

By Deborah OMalley, InvestorPlace Writer
Solar stocks are among the investments hitting new 52 week lows today in the stock market as pharmaceutical companies hit new highs.

New AIDS Therapies May Shake Up Big Pharma Profits

By Barry Cohen, Health Care Writer
Vaccines and transplants may usher in new players

Selloff in Pharma United Therapeutics and Exelixis

By Anthony John Agnello, Consumer and Technology Writer
Volume leaders in midday trading included Credicorp (NYSE: BAP), Lorillard (NYSE: LO), United Therapeutics Corp. (NASDAQ: UTHR).

Could Legalized Pot Give Big Pharma a Much-Needed Boost?

By Barry Cohen, Health Care Writer
Medical marijuana is big business where it's legalized, and if major pharmaceutical companies could get a share of the market they could see a big boost.

Johnson & Johnson Stock a Buy With Healthy Performance Ahead

By Hilary Kramer, Editor, GameChangers
After some recalls, Johnson & Johnson earnings are back on track. Along with a nice dividend, that makes it a good buy.

CVS Grabs Options and Huge Fed Contract

By OptionsZone Experts
CVS Caremark (NYSE: CVS) wins $3 billion federal contract and options volume jumps in midday trading.

Clean Diesel and Tiffany Top Busy Stocks

By Anthony John Agnello, Consumer and Technology Writer
Stocks seeing big jumps in volume this morning include Tiffany (NYSE: TIF), Clean Diesel Technology (NASDAQ: CDTI), hhgregg (NYSE: HGG).

Vertex vs. Merck in Hepatitis Drug Title Fight

By Barry Cohen, Health Care Writer
All that's at stake is a $10 billion market.

Overseas Drug Test Trend May Cost AstraZeneca

By Barry Cohen, Health Care Writer
The company's promising heart drug may face delays

LinkedIn Options to Start Next Week

By OptionsZone Experts
Options on LinkedIn (NYSE: LNKD) could start trading on Friday, May 27.
Load More